IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients h | Rheumatology Updates
IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients https://www.medscape.com/viewarticle/991881?src=rss
The rate of venous thromboembolism did not increase in dermatomyositis patients treated with intravenous immunoglobulin, compared with those not treated with IVIG. MDedge News
